Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

Condition(s) studied

Investigational drug(s) / intervention(s)

Observational: Observational

Study summary

This study will be a multi-institutional, prospective, observational study of patients with localized primary AS of any site within ISG and RTR centers. Patients will be treated according to clinical practice of the center and according to ISG clinical recommendations on localized AS.

Eligibility

Primary outcome measure(s)

• Demographic characteristics — At the time of enrollment
  Demographic data
• General characteristics — At the time of enrollment
  Comorbidities
• Cancer data — At the time of enrollment
  Previous cancer data
• Origin of Tumor — At the time of enrollment
  Site of origin
• Tumor characteristics — At the time of enrollment
  Multifocality
• Tumor size — At the time of enrollment
  Size
• Tumor aspects — 10 years
  Morphological aspects
• Pathological characteristics — 10 years
  Proliferative index
• Tumor phenotype — 10 years
  Tumor cell phenotype
• Molecular characteristics — 10 years
  Molecular aspects

Trial sites (19)

More Italian Sarcoma Group trials in Italy